Haley Collins
Director, Head of Corporate Communications
Replay available
Taysha Gene Therapies, Inc. (TSHA) Q1 2025 Earnings Call
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) Q1 2025 earnings conference call, held 2025-05-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Sean Nolan
Chief Executive Officer
Sigmar Nagandran
President and Head of R&D
Cameron Alam
Chief Financial Officer
Kristin Kluska
Analyst, Cantor & Co.
Joel Blump
Analyst, Needham & Co.
Morrie Graycroft
Analyst, Jefferies & Co.
Yanan Zhu
Analyst, Wolfe Research
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Taysha Gene Therapies, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.051 -- 00:00:05.713 Greetings, and welcome to the Tatia Gene Therapy's first quarter 2025 earnings 00:00:05.713 -- 00:00:10.755 call. At this time, all participants are in listen-only mode. 00:00:10.755 -- 00:00:14.897 The question and answer session will follow the formal presentation. 00:00:14.897 -- 00:00:19.299 If anyone should require operator assistance during the conference, please press star 00:00:19.299 -- 00:00:22.180 then zero on your telephone keypad. 00:00:22.180 -- 00:00:24.601 As a reminder, this conference is being recorded. 00:00:24.601 -- 00:00:30.065 I would now like to turn the conference over to your host, Haley Collins, Director, 00:00:30.065 -- 00:00:34.287 Head of Corporate Communications. Please go ahead. 00:00:34.709 -- 00:00:39.673 Thank you. Good morning and welcome to Tayshia's first quarter 2025 financial results 00:00:39.673 -- 00:00:44.497 and corporate update conference call. Earlier today, Tayshia issued a press release announcing 00:00:44.497 -- 00:00:49.240 financial results for the first quarter ended March 31st, 2025. 00:00:49.240 -- 00:00:53.244 A copy of this press release is available on the company's website and through our SEC 00:00:53.244 -- 00:00:58.644 filing. Joining me on today's call are Sean Nolan, Cassius Chief Executive Officer, 00:00:58.644 -- 00:01:04.411 Sigmar Nagandran, President and Head of R&D, and Cameron Alam, Chief Financial Officer. 00:01:04.411 -- 00:01:09.134 We will hold a question and answer session following our prepared remarks. 00:01:09.537 -- 00:01:14.281 Please note that on today's call, we will be making forward-looking statements 00:01:15.843 -- 00:01:20.276 102, including the reproducibility and durability of any favorable results initially 00:01:20.276 -- 00:01:24.798 seen in ...